Nutrition and gastrointestinal health as modulators of parkinson’s disease

AAPS Advances in the Pharmaceutical Sciences Series

Volumn 12, Issue , 2014, Pages 213-242

  Rasmussen, Heather E ^a   Piazza, Bryana R ^a   Forsyth, Christopher B ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; SYNBIOTIC AGENT;

ARTICLE; DIETARY INTAKE; DISEASE COURSE; EATING HABIT; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INFLAMMATION; INTESTINAL BARRIER; META ANALYSIS (TOPIC); MOTOR PERFORMANCE; NONHUMAN; NUTRITION; PARKINSON DISEASE; PATHOGENESIS; PERMEABILITY BARRIER; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 85081145812     PISSN: 22107371     EISSN: 2210738X     Source Type: Book Series    
DOI: 10.1007/978-3-319-06151-1_11     Document Type: Article

References (153)

1. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57(3):456–462
2. Ahrne SH, Marie-Louise H (2011) Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3(1):104–117
3. Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N (2012) The association between Mediterranean diet adherence and Parkinson’s disease. Mov Disord 27(6):771–774
4. Alenka S, Bengmark S, Vovk I, Cerovic O, Kompan L (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 31(2):119–126
5. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD (1999) Dietary factors in Parkinson’s disease: the role of food groups and specific foods. Mov Disord 14(1):21–27
6. Anderson RC, Cookson AL, McNabb WC, Kelly WJ, Roy NC (2010) Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett 309(2):184–192
7. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW (2009) Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring, Md) 17(11):2100–2102
8. Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM (1997) Constipation in Parkinson’s disease: objective assessment and response to psyllium. Mov Disord 12(6):946–951
9. Astarloa R, Mena MA, Sánchez V, de la Vega L, de Yébenes JG (1992) Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol 15(5):375–380
10. Baffoni L, Gaggìa F, Di Gioia D, Santini C, Mogna L, Biavati B (2012) A Bifidobacteriumbased synbiotic product to reduce the transmission of C. jejuni along the poultry food chain. Int J Food Microbiol 157(2):156–161
11. Beal MF, Matthews RT, Tieleman A, Shults CW (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3, tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 783(1):109–114
12. Benton D, Williams C, Brown A (2007) Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61(3):355–361
13. Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F (2006) The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose–response relationship study in healthy humans. Nutrition J 5
14. Bousquet M, Calon F, Cicchetti F (2011) Impact of omega-3 fatty acids in Parkinson’s disease. Ageing Res Rev 10(4):453–463
15. Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease. FASEB J 22(4):1213–1225
16. Bousquet M, St-Amour I, Vandal M, Julien P, Cicchetti F, Calon F (2012) High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice. Neurobiol Dis 45(1):529–538
17. Braak H, De Vos RAI, Bohl J, Del Tredici K (2006) Gastric a-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s diseaserelated brain pathology. Neurosci Lett 396(1):67–72
18. Braak H, Del Tredici K (2008) Invited Article: nervous system pathology in sporadic Parkinson disease. Neurology 70(20):1916–1925
19. Braak H, Rüb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110(5):517–536
20. Brinkworth GD, Noakes M, Clifton PM, Bird AR (2009) Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101(10):1493–1502
21. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti J, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772
22. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103
23. Casani S, Gomez-Pastor R, Matallana E, Paricio N (2013) Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson’s disease. Free Radic Biol Med 61C:151–160
24. Cersosimo MG, Benarroch EE (2012) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46(3):559–564
25. Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23(8):1065–1075
26. Chen H, O’Reilly E, McCullough ML, Rodriguez C, Schwarzschild MA, Calle EE, Thun MJ, Ascherio A (2007) Consumption of dairy products and risk of parkinson’s disease. Am J Epidemiol 165(9):998–1006
27. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A (2003) Dietary intakes of fat and risk of Parkinson’s disease. Am J Epidemiol 157(11):1007–1014
28. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Willett WC, Ascherio A (2004) Obesity and the risk of Parkinson’s disease. Am J Epidemiol 159(6):547–555
29. Chen JJ, Wang R, Li X, Wang R (2011) Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal reg I gene expression. Exp Biol Med 236(7):823–831
30. Cleren C, Yang L, Lorenzo B, Calingasan N, Schomer A, Sireci A, Wille E, Beal MF (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104(6):1613–1621
31. Davis LMG, Martínez I, Walter J, Hutkins R (2010) A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 144(2):285–292
32. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107(33):14691–14696
33. De Lau LML, Bornebroek M, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MMB (2005) Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study. Neurology 64(12):2040–2045
34. Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia C, Mohanty P, Viswanathan P, Chaudhuri A, Dandona P (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33(5):991–997
35. Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, Naveilhan P, Nguyen J, Neunlist M, Derkinderen P (2013) Colonic inflammation in Parkinson’s disease. Neurobiol Dis 50(1):42–48
36. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PGB, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen J, Delzenne NM (2012) Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62(8):1112–1121
37. Djaldetti R, Lev N, Melamed E (2009) Lesions outside the CNS in Parkinson’s disease. Mov Disord 24(6):793–800
38. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68 (5):384–386
39. Duncan G, Khoo T, Yarnall A, O’Brien J, Coleman S, Brooks D, Barker R, Burn D (2014) Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord 29(2):195–202
40. Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O’Sullivan GC, Shanahan F, Collins JK (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73(2 Suppl):386S–392S
41. Elm J (2012) Design innovations and baseline findings in a long-term Parkinson’s trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson’s Disease Long-Term Study-1. Mov Disord 27(12):1513–1521
42. Erridge C, Attina T, Spickett C, Webb D (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86(5):1286–1292
43. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Garcia E, Ruiz- Gutierrez V, Fiol M, Lapetra J, and Lamuela-Raventos RM (2013) Primary prevention of cardiovascular disease with a mediterranean diet. N Eng J Med 368:1279–1290
44. Etminan M, Gill S, Samii A (2005) Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: a meta-analysis. Lancet Neurol 4(6):362–365
45. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GM, Neyrinck AM, Possemiers S, Van Holle A, François P, De Vos WM, Delzenne NM, Schrenzel J, Cani PD (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11):2775–2786
46. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A (2003) Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B: Analyt Technol Biomed Life Sci 784(1):145–154
47. Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA (2013) The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ’at-risk’ population. Int J Obes 37(2):216–223
48. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS One 6(12):e28032
49. Froy O, Miskin R (2010) Effect of feeding regimens on circadian rhythms: implications for aging and longevity. Aging 2(1):7–27
50. Fukata M, Arditi M (2013) The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 6(3):451–463
51. Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A (2007) Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 86 (5):1486–1494
52. Ghanim H, Abuaysheh S, Sia C, Korzeniewski K, Chaudhuri A, Fernandez Real J, Dandona P (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32(12):2281–2287
53. Gibson G, Scott K, Rastall R, Tuohy K, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy E, Saulnier D, Loh G (2010) Dietary prebiotics: current status and new definition. Food Sci Technol Bull: Functional Foods 7:1–19
54. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412
55. Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355–1359
56. Grandinetti A, Morens DM, Reed D, MacEachern D (1994) Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson’s disease. Am J Epidemiol 139 (12):1129–1138
57. Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED, Carson RE, Ding YS, Cosgrove KP (2012) Endotoxin-induced systemic inflammation activates microglia: [(1) (1)C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 63(1):232–239
58. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599–614
59. Hobson P, Meara J, Ishihara-Paul L (2010) The estimated life expectancy in a community cohort of Parkinson’s disease patients with and without dementia, compared with the UK population. J Neur, Neurosurg Psychiatr 81(10):1093–1098
60. Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J (2006) Body mass index and the risk of Parkinson disease. Neurology 67(11):1955–1959
61. Hwang O (2013) Role of oxidative stress in Parkinson’s disease. Exp Neurobiol 22(1):11–17
62. John LJ, Fromm M, Schulzke J (2011) Epithelial barriers in intestinal inflammation 15:1255–1270
63. Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM (2014) Dietary fat intake, pesticide use, and Parkinson’s disease. Parkinsonism Relat Disord 20(1):82–87
64. Kaye J, Gage H, Kimber A, Storey L, Trend P (2006) Excess burden of constipation in Parkinson’s disease: a pilot study. Mov Disord 21(8):1270–1273
65. Khoo T, Yarnall A, Duncan G, Coleman S, O’Brien J, Brooks D, Barker R, Burn D (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281
66. Kolida S, Gibson GR (2011) Synbiotics in health and disease. Ann Rev Food Sci Technol 2:373–393
67. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37(7):1253–1255
68. Kurlan R, Rothfield KP, Woodward WR, Nutt JG, Miller C, Lichter D, Shoulson I (1988) Erratic gastric emptying of levodopa may cause ’random’ fluctuations of parkinsonian mobility. Neurology 38(3):419–421
69. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A (2013) Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol 28(1):67–77
70. Laugerette F, Vors C, Géloën A, Chauvin M-A, Soulage C, Lambert-Porcheron S, Peretti N, Alligier M, Burcelin R, Laville M, Vidal H, Michalski M-C (2011) Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 22 (1):53–59
71. Leber B, Tripolt NJ, Blattl D, Eder M, Wascher TC, Pieber TR, Stauber R, Sourij H, Oettl K, Stadlbauer V (2012) The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr 66(10):1110–1115
72. Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, Naveilhan P, Galmiche J, Bruley Des Varannes S, Derkinderen P, Neunlist M (2008) Pathological lesions in colonic biopsies during Parkinson’s disease. Gut 57(12):1741–1743
73. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley Des Varannes S, Neunlist M, Derkinderen P (2009) The second brain and Parkinson’s disease. Eur J Neurosci 30(5):735–741
74. Lebouvier T, Coron E, Chaumette T, Paillusson S, Des Varannes SB, Neunlist M, Derkinderen P (2010) Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil 22(1):e11–e14
75. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N’Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P (2010) Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PloS One 5(9):e12728
76. Lee H-J, Suk J-E, Lee K-W, Park S-H, Blumbergs P, Gai W-P, Lee S-J (2011) Transmission of synucleinopathies in the enteric nervous system of A53T alpha-synuclein transgenic mice. Exp Neurobiol 20(4):181–188
77. Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373(9680):2055–2066
78. Logroscino G, Marder K, Cote L, Tang M, Shea S, Mayeux R (1996) Dietary lipids and antioxidants in Parkinson’s disease: a population- based, case–control study. Ann Neurol 39 (1):89–94
79. Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM (2012) Pathological a-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949–953
80. Maes M (2009) Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatr 22(1):75–83
81. Maes M, Kubera M, Leunis JC (2008) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29(1):117–124
82. Magerkurth C, Schnitzer R, Braune S (2005) Symptoms of autonomic failure in Parkinson’s disease: prevalence and impact on daily life. Clin Auton Res 15(2):76–82
83. Mani V, Hollis J, Gabler N (2013) Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab 10(1):6–6
84. Martinez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG, Louk JA, Rose DJ, Kyureghian G, Peterson DA, Haub MD, Walter J (2013) Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 7(2):269–280
85. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157 (1):142–149
86. Ménard S, Cerf-Bensussan N, Heyman M (2010) Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 3(3):247–259
87. Messay B, Lim A, Marsland AL (2012) Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Anxiety Disord 2(1):4
88. Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M (2010) Dietary fat intake and risk of Parkinson’s disease: a case–control study in Japan. J Neurol Sci 288(1–2):117–122
89. Morelli M, Carta AR, Kachroo A, Schwarzschild MA (2010) Pathophysiological roles for purines. Adenosine, caffeine and urate. Prog Brain Res 183:183–208
90. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR (1996) Case–control study of idiopathic Parkinson’s disease and dietary vitamin E intake. Neurology 46(5):1270–1274
91. Muller T, Buttner T, Gholipour AF, Kuhn W (2003) Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson’s disease. Neurosci Lett 341 (3):201–204
92. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110 (3):650–657
93. Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H (2013) Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol 74(3):472–477
94. Nussbaum RL, Ellis CE (2003) Alzheimer’s disease and Parkinson’s disease. N Engl J Med 348(14):1356–1364
95. Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL (1984) The "on-off" phenomenon in Parkinson’s disease. Relation to levodopa absorption and transport. N Engl J Med 310(8):483–488
96. Olanow CW, Brundin P (2013) Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Mov Disord 28(1):31–40
97. Orr SK, Trépanier M, Bazinet RP (2013) N-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot Essent Fatty Acids 88(1):97–103
98. Palacios N, Gao X, Mccullough ML, Jacobs EJ, Patel AV, Mayo T, Schwarzschild MA, Ascherio A (2011) Obesity, diabetes, and risk of Parkinson’s disease. Mov Disord 26 (12):2253–2259
99. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RHW (2010) Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5(1):e8762
100. Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O’Sullivan GA, Pal A, Said J, Marsico G, Verbavatz J, Rodrigo-Angulo M, Gille G, Funk RHW, Reichmann H (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898
101. Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P (2005) Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 156(2):256–262
102. Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14 (2):223–236 discussion 222
103. Pouclet H, Lebouvier T, Coron E, BruleydesVarannes S, Rouaud T, Roy M, Neunlist M, Derkinderen P (2012) A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson’s disease. Neurobiol Dis 45(1):305–309
104. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2003) Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60(11):1761–1766
105. Prusiner SB (2012) A unifying role for prions in neurodegenerative diseases. Science 336 (6088):1511–1513
106. Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease. Gastroenterology 87 (4):848–856
107. Rao AV, Bested A, Beaulne T, Katzman M, Iorio C, Berardi J, Logan A (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 1(1):6–6
108. Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM (2013) Dysregulated relationship of inflammation and oxidative stress in major depression. Brain, Behav Immun 31:143–152
109. Reddy BS, MacFie J, Gatt M, Larsen CN, Jensen SS, Leser TD (2007) Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 94(5):546–554
110. Renoudet V, Costa Mallen P, Hopkins E (2012) A diet low in animal fat and rich in N-hexacosanol and fisetin is effective in reducing symptoms of Parkinson’s disease. J Med Food 15(8):758–761
111. Roberfroid M, Gibson G, Hoyles L, McCartney A, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco M-J, Léotoing L, Wittrant Y, Delzenne N, Cani P, Neyrinck A, Meheust A (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(2):S1–63
112. Rodes L, Khan A, Paul A, Coussa Charley M, Marinescu D, Tomaro Duchesneau C, Shao W, Kahouli I, Prakash S (2013) Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J Microbiol Biotechnol 23(4):518–526
113. Russo F, Linsalata M, Clemente C, Chiloiro M, Orlando A, Marconi E, Chimienti G, Riezzo G (2012) Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutr Res 32 (12):940–946
114. Saaksjarvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Mannisto S (2008) Prospective study of coffee consumption and risk of Parkinson’s disease. Eur J Clin Nutr 62(7):908–915
115. Saleem T, Higginson I, Chaudhuri KR, Martin A, Burman R, Leigh PN (2013) Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson’s disease and related neurological conditions. Palliat Med 27(8):722–731
116. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA (2009) Medical records documentation of constipation preceding Parkinson disease: a case–control study. Neurology 73(21):1752–1758
117. Savidge TC, Sofroniew MV, Neunlist M (2007) Starring roles for astroglia in barrier pathologies of gut and brain. Lab Invest 87(8):731–736
118. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s Disease? Evidence from 3 cases. Mov Disord 27(6):716–719
119. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH (2012) Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Mov Disord 27(6):709–715
120. Shprecher DR, Derkinderen P (2012) Parkinson disease: the enteric nervous system spills its guts. Neurology 78(9):683, author reply 683
121. Shults CW, Haas RH, Passov D, Beal MF (1997) Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42(2):261–264
122. Shults C, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos J, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter J, Reich S, Stern M, Watts R, Kurlan R, Molho E, Harrison M, Lew M (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59(10):1541–1550
123. Shults CW (2006) Lewy bodies. Proc Natl Acad Sci U S A 103(6):1661–1668
124. Shults CW (2006) Lewy bodies. Proc Natl Acad Sci U S A 103(6):1661–1668
125. Siderowf A, Lang AE (2012) Premotor Parkinson’s disease: concepts and definitions. Mov Disord 27(5):608–616
126. Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29(5):508–518
127. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EMM (1995) Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet 346(8979):861–864
128. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008) Adherence to Mediterranean diet and health status: meta-analysis. BMJ 337(7671):673–675
129. Stratiki Z, Costalos C, Sevastiadou S, Kastanidou O, Skouroliakou M, Giakoumatou A, Petrohilou V (2007) The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 83(9):575–579
130. Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ (2006) Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an - evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66(7):976–982
131. Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, Vitaterna MH, Song S, Turek FW, Keshavarzian A (2013) Disruption of the circadian clock in mice increases intestinal permeability and promotes alcohol-induced hepatic pathology and inflammation. PloS One 8(6):e67102
132. Tangney CC, Rasmussen HE (2013) Polyphenols, inflammation, and cardiovascular disease. Curt Atheroscler Rep 15(5):324
133. Tarnopolsky MA, Beal MF (2001) Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 49(5):561–574
134. Thomas B, Beal MF (2007) Parkinson’s disease. Human Mol Genet 16(2):R183–R194
135. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain Raspaud S, Trotin B, Naliboff B, Mayer E (2013) Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144(7):1394–1401, 1401.e1
136. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14
137. Tzounis X, Rodriguez Mateos A, Vulevic J, Gibson G, Kwik Uribe C, Spencer JP (2011) Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93(1):62–72
138. U.S. Department of Agriculture, Agricultural Research Service (2012) Nutrient Intakes from Food: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat in America,NHANES 2009–2010. Available: www.ars.usda.gov/ba/bhnrc/fsrg. Accessed 4 Sep 2012
139. van Zanten GC, Knudsen A, Röytiö H, Forssten S, Lawther M, Blennow A, Lahtinen SJ, Jakobsen M, Svensson B, Jespersen L (2012) The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One 7(10):e47212
140. Vulevic J, Juric A, Tzortzis G, Gibson GR (2013) A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults1-3. J Nutr 143(3):324–331
141. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79(6):581–583
142. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F (1993) Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Adv Neurol 60:609–612
143. Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z (2006) The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma - Injury, Infection, Critical Care 61 (3):650–657
144. White JF (2003) Intestinal pathophysiology in autism. Exp Biol Med (Maywood, NJ) 228 (6):639–649
145. Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS (2013) Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson’s disease: insights from a transgenic mouse model. Exp Neurol 243:57–66
146. Wirdefeldt K, Adami H, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1–S58
147. Wong JMW, Esfahani A, Singh N, Villa CR, Mirrahimi A, Jenkins DJA, Kendall CWC (2012) Gut microbiota, diet, and heart disease. J AOAC Int 95(1):24–30
148. World Health Organization. Available: http://www.who.int/mental_health/management/ depression/definition/en/index.html
149. Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh S, Bewtra M, Knights D, Walters W, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman F, Lewis J (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105–108
150. Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74(11):924–931
151. Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS (2009) Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 206(1–2):121–124
152. Zhong Y, Cai D, Cai W, Geng S, Chen L, Han T (2009) Protective effect of galactooligosaccharide-supplemented enteral nutrition on intestinal barrier function in rats with severe acute pancreatitis. Clin Nutr 28(5):575–580
153. Tan LC, Koh W-P, Yuan J-M, Wang R, Au W-L, Tan JH, Tan EK, Yu MC (2008) Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese health study. Am J Epidemiol 167(5):553–560